Skip to main content
Premium Trial:

Request an Annual Quote

Canopy Biosciences Licenses WUSTL NGS Technology

NEW YORK (GenomeWeb) – Canopy Biosciences announced today that it has obtained an exclusive license for error correction technology in next-generation sequencing from Washington University in St. Louis.  

According to the firm, the license contains both a unique method and bioinformatic tools that improve the level of detection in NGS, allowing researchers to identify ultra-rare gene variants.

"Given their ever-expanding applications for this technology, [Canopy is] committed to making innovation accessible to researchers, which will facilitate another level of insight into disease through NGS," co-inventor and WUSTL associate pediatrics professor Todd Druley said in a statement.

Canopy plans to launch a service based on the license by the second quarter of 2019.

"The power that this technology brings to genomic sequencing is game-changing; taking the error rate for NGS from 5 in 100 sequencings to 1 in 10,000," Canopy Biosciences CEO Edward Weinstein said in a statement. "Such a significant improvement over the current methods has remarkable implications for the research community, but the potential for error corrected sequencing in the clinical space will change the way patients are tested."

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.